Brief: Transgene Appoints Hedi Ben Brahim As Chairman And CEO
Dec 3 (Reuters) - Transgene SA TRNG.PA :
* TRANSGENE APPOINTS HEDI BEN BRAHIM AS CHAIRMAN AND CHIEF
EXECUTIVE OFFICER
* APPOINTMENT OF HEDI BEN BRAHIM AS COMPANY'S NEW CHAIRMAN
AND
CEO, EFFECTIVE JANUARY 1ST, 2021
Source text for Eikon: ID:nBw5Xxmzza
Further company coverage: TRNG.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Transgene SA
See all newsFrance's Transgene H1 operating income falls on lower tax credit
Transgene jumps 20% on positive cancer vaccine data in early trial
Brief: Transgene & NEC Bio Sign License Agreement To Prepare Next Steps Of Development Of TG4050 In Head & Neck Cancer
Brief: Transgene SA Says Myvac Platform To Initiate Phase 1 Trial In Second Indication In 2026
France's Transgene 2025 net loss widens on higher financial costs